Authored by Aldgra Fredly via The Epoch Times,
President Donald Trump said on May 8 that he has no plans to replace Marty Makary as commissioner of the U.S. Food and Drug Administration (FDA).
When asked by reporters outside the White House about Makary, Trump responded:“Nothing much, he’s doing fine,”without elaborating further.
Trump said he had seen reports suggesting the administration was planning to remove Makary from his role leading the FDA, but added thathe knows “nothing about it.”
The president also rejected the notion that he would hire someone new to replace Makary.
Amid the media speculation, White House spokesman Kush Desai said in a statement to multiple news outlets that Trump “has assembled the most experienced and talented administration in history.”
Several media outlets, citing unnamed sources, on May 8 stated that the president intends to remove Makary after controversies surrounding abortion drug mifepristone.
A federal appeals court on May 1blockedthe mailing of mifepristone until the FDA can ensure the abortion drug is “safe and effective” for use in the United States. The Supreme Court laterputthe ruling on hold after pill maker Danco Laboratories requested an emergency stay.
Mifepristone has long been available to women after consulting with doctors. In 2023, federal authorities enabled access via mail and at pharmacies.
In its May 1 ruling, the U.S. Court of Appeals for the Fifth Circuit said mifepristone could not be shipped because the FDA “conceded it had failed to adequately study whether remotely prescribing mifepristone is safe.”
Source: ZeroHedge News
